A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing Leqembi up for authorization in a major market.

Eisai Co., Ltd. (ESALF.PK) and Biogen Inc. (BIIB) announced a positive opinion has been received from the Committee for Medicinal ...

A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...

Now, it's up to the European Commission to confirm those potential green lights in the coming weeks and months.

Biogen Inc.’s BIIB Japan-based partner, Eisai announced that the European Medicines Agency’s (EMA) Committee for Medicinal ...

Shenzhen, China, Nov. 15, 2024 (GLOBE NEWSWIRE) -- 3i proudly announces the release of its captivating New Brand Video, ...

Nike’s new Elite EasyOn backpack was designed with innovative features making it accessible for as many athletes as possible, ...

Nissan Motor shares jumped as much as 6% in early Tokyo trading on Friday after Japan's Diamond Online magazine reported that ...

4. Microsoft: Windows to the Digital World Microsoft logo has changed many times, with the present version combining the company's history and future in a single design. This logo is simple because it ...